Literature DB >> 18159971

Prostate-specific antigen levels among Chinese, Malays and Indians in Singapore from a community-based study.

Sin-Eng Chia1, Weber Ko Lau, Christopher Cheng, Chong Min Chin, James Tan, Siew Hong Ho.   

Abstract

The purpose of this study was to examine the distribution of prostate-specific antigen levels among Chinese, Malays and Indians in Singapore, taking the effect of age into consideration. The study was carried out as part of the Singapore Prostate Awareness Week from 23-26th February 2004. Men above 50 years old went to four government-restructured hospitals to participate in the study. Participants filled up a questionnaire and provided 5 ml of blood for measurement of PSA levels using the Abbott IMx Total PSA assay (Abbott Laboratories). 3,486 men responded to the study, comprising 92.8% Chinese, 3.0% Malays, 2.5% Indians and 1.8% Others. 92.7% of them had PSA levels of 4 microg/L or less. There were no significant differences (p<0.05) between the mean PSA levels of Chinese (1.60 microg/L), Malays (1.39 microg/L), Indians (1.23 microg/L) and Others (1.70 microg/L). PSA levels were significantly associated with age (Spearman's r= 0.27, p<0.01). PSA levels increased with each 10-year age group and these trends were significant (p<0.0001) across both PSA group levels and age groupings. In the <or=50 and >50-60 years age groups, the prevalence of PSA levels >4 mug/L were 1.1% and 3.7% respectively. This rose rapidly to 11.3% and 23.5% for age groups >60-70 and >80 years respectively. Our study shows that the median PSA levels in the Caucasian population in the USA are higher than those of Chinese, Malays and Indians in Singapore. PSA levels were positively associated with age. It may be more appropriate to offer PSA testing to men who are >60 years old rather than the current >50 years.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18159971

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

Review 1.  An overview of prostate diseases and their characteristics specific to Asian men.

Authors:  Shu-Jie Xia; Di Cui; Qi Jiang
Journal:  Asian J Androl       Date:  2012-02-06       Impact factor: 3.285

2.  An inverse association of body mass index and prostate-specific antigen in northwest men of China: a population-based analysis.

Authors:  Jianqin Zhang; Binwu Sheng; Mao Ma; Xunyi Nan
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  The value of prostate-specific antigen in Asia.

Authors:  Chaidir Arif Mochtar; R Siddhi Andika
Journal:  Ther Adv Urol       Date:  2010-04

Review 4.  Demography and disease characteristics of prostate cancer in India.

Authors:  Krishnamoorthy Hariharan; Venugopal Padmanabha
Journal:  Indian J Urol       Date:  2016 Apr-Jun

Review 5.  Prostate cancer in Asian men.

Authors:  Kazuto Ito
Journal:  Nat Rev Urol       Date:  2014-03-04       Impact factor: 14.432

6.  Ethnicity is an independent determinant of age-specific PSA level: findings from a multiethnic Asian setting.

Authors:  Jasmine Lim; Nirmala Bhoo-Pathy; Selvalingam Sothilingam; Rohan Malek; Murali Sundram; Badrul Hisham Bahadzor; Teng Aik Ong; Keng Lim Ng; Sivaprakasam Sivalingam; Azad Hassan Abdul Razack
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

7.  Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China.

Authors:  J Zhang; M Ma; X Nan; B Sheng
Journal:  Braz J Med Biol Res       Date:  2016-07-11       Impact factor: 2.590

8.  Contemporary outcomes in the detection of prostate cancer using transrectal ultrasound-guided 12-core biopsy in Singaporean men with elevated prostate specific antigen and/or abnormal digital rectal examination.

Authors:  Alvin Lee; Sing Joo Chia
Journal:  Asian J Urol       Date:  2015-09-03

9.  A hospital based study on reference range of serum prostate specific antigen levels.

Authors:  Aditi Gupta; Deepa Gupta; Arun Raizada; Narmada Prasad Gupta; Rajiv Yadav; Kamini Vinayak; Vijay Tewari
Journal:  Indian J Med Res       Date:  2014-10       Impact factor: 2.375

10.  The PREVAIL trial of enzalutamide in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients.

Authors:  Choung-Soo Kim; Ad Theeuwes; Dong Deuk Kwon; Young Deuk Choi; Byung Ha Chung; Hyun Moo Lee; Kang Hyun Lee; Sang Eun Lee
Journal:  Investig Clin Urol       Date:  2016-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.